Prescribing of drugs for Alzheimer's disease: A South African database analysis

International Psychogeriatrics

Volumn 22, Issue 2, 2010, Pages 264-269

  Truter, Ilse ^a  

^a NELSON MANDELA METROPOLITAN UNIVERSITY   (South Africa)

Author keywords

Defined daily dose (DDD); Dementia; Drug utilization study; Memantine; Prescribing patterns; Private health care sector; South Africa

Indexed keywords

DONEPEZIL; GALANTAMINE; MEMANTINE; RIVASTIGMINE; INDAN DERIVATIVE; NOOTROPIC AGENT; PIPERIDINE DERIVATIVE;

AGED; ALZHEIMER DISEASE; ARTICLE; CAREGIVER; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DATA BASE; DRUG COST; FAMILY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; RETROSPECTIVE STUDY; SOUTH AFRICA; CLINICAL PRACTICE; COST; COST BENEFIT ANALYSIS; ECONOMICS; STATISTICS;

AGED; ALZHEIMER DISEASE; COHORT STUDIES; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; DRUG PRESCRIPTIONS; FEMALE; GALANTAMINE; HUMANS; INDANS; MALE; MEMANTINE; NOOTROPIC AGENTS; PHYSICIAN'S PRACTICE PATTERNS; PIPERIDINES; RETROSPECTIVE STUDIES; SOUTH AFRICA;

EID: 77950569552     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610209991530     Document Type: Article

References (13)

1. Barclay, L. (2009). Cholinesterase inhibitors linked to serious adverse events in older adults with dementia. Medscape Medical News, CME/CE Activity (20 May 2009). Available at: http://www.medscape.com/viewarticle/703039 (last accessed 28 May 2009).
2. Beers, M. H. et al. (eds.). (2006). The Merck Manual of Diagnosis and Therapy. 18th edn. Whitehouse Station, NJ: Merck Research Laboratories.
3. Capella, D. (1993). Descriptive tools and analysis. In M. N. G. Dukes (ed.), Drug Utilization Studies: Methods and Uses (pages 55-78). Copenhagen: WHO Regional Publications, European Series No. 45.
4. Chandra, V. et al. (1994). Studies of the epidemiology of dementia: comparisons between developed and developing countries. Aging: Clinical and Experimental Research, 6, 307-321.
5. Gibbon, C. J. (ed.) (2008). South African Medicines Formulary. 8th edn. Cape Town: Health and Medical Publishing Group of the South African Medical Association.
6. Gill, S. S. et al. (2009). Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: population-based cohort study. Archives of Internal Medicine, 169, 867-873.
7. Ineichen, B. (1996). The prevalence of dementia and cognitive impairment in China. International Journal of Geriatric Psychiatry, 11, 695-697.
8. Ineichen, B. (2000). The epidemiology of dementia in Africa: a review. Social Science and Medicine, 50, 1673-1677.
9. MediFile (2006). Memantine in Alzheimer's disease.MediFile: Drug Information Bulletin, 9, 37-40, Johannesburg: MediKredit.
10. Mobius, H. J. (2003). Memantine: update on the current evidence. International Journal of Geriatric Psychiatry, 18, S47-S54. doi:10.1002/gps.939. (Pubitemid 37150478)
11. NICE (2007). Donepezil, Galantamine, Rivastigmine (Review) and Memantine for the Treatment of Alzheimer's Disease (Amended). Quick Reference Guide. London: National Institute for Health and Clinical Excellence.
12. Snyman, J. R. (ed.) (2007). Mims Medical Specialities. Vol. 47, Saxonwold: MIMS.
13. WHO Collaborating Centre (2009). ATC/DDD Index 2009. WHO Collaborating Centre for Drug Statistics Methodology. Available at: http://www.whocc.no/ atcddd/indexdatabase (last accessed 23 April 2009).